In this second installment of Intel’s Jam Session, a panel of experts discuss the current trends, burgeoning innovations, and future trajectory of digital solutions for clinical practice and…
For their 2021 Future of Healthcare & Medicine conference, the MIT Club of Northern California invited founders, technologists, investors, and industry leaders who are working to build the…
NEW YORK (Reuters Health) – In pregnant women with acute trauma, computed tomography accurately identifies placental abruption, Arizona researchers report. Up to 40% of pregnant women with severe…
NEW YORK (Reuters Health) – Adjuvant chemotherapy, with or without postoperative radiotherapy, improves survival in patients with operable non-small-cell lung cancer, according to a March 24th online report…
NEW YORK (Reuters Health) – High-potency, stereotactic body radiation therapy (SBRT) may improve survival for patients with medically inoperable early stage lung cancer, results of a multicenter phase…
NEW YORK (Reuters Health) – A normal coronary artery calcium (CAC) scan in middle-age appears to have a “warranty period” of about four years, during which the patient…
NEW YORK (Reuters Health) – Just 38% of patients with suspected cardiac disease are found to have obstructive coronary disease on elective cardiac catheterization, new research shows. This…
Andrew Charles, MD, Professor, Director of Headache Research and Treatment Program, UCLA David Geffen School of Medicine, discusses when to get a scan for a headache and the…
NEW YORK (Reuters Health) – Three weeks of hypofractionated whole-breast radiotherapy is at least as good as 5 weeks of standard radiotherapy after breast-conserving surgery for invasive cancer,…
NEW YORK (Reuters Health) – In women over 55, simple ovarian cysts are common, usually resolving or persisting without progression, according to data from the prospective Prostate, Lung,…
NEW YORK (Reuters Health) – Sonographic surveillance of newborns with mild hip dysplasia can reduce the need for early abduction splinting without increasing the risk of persistent or…
NEW YORK (Reuters Health) – In patients with middle cerebral artery occlusion, an alteplase dosage of 0.6 mg/kg IV is comparable to a 0.9 mg/kg dosage for achieving…
